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The use of insecticide treated nets
(ITNs), and subsequently the new gener-
ation of long-lasting insecticide treated
nets (LLINs), has been a core malaria
prevention strategy for more than two
decades [1], and until 2010, distribution of
LLINs targeted biologically vulnerable
groups such as pregnant women and
children aged less than 5 years [2,3]. In
2008, due largely to increased funding for
malaria control leading to impressive gains
in LLIN coverage, the Roll Back Malaria
(RBM) Partnership set a more ambitious
target of universal coverage of LLINs,
defined as universal access to, and use of,
LLINs [4,5].
The strategy for achieving and main-
taining universal coverage outlined by the
RBM Partnership involves a combination
of strategies based on mass campaigns,
either target-specific or population-wide,
to rapidly scale up coverage (‘‘catch up’’),
complemented by continuous distribution
through routine health services, including
antenatal clinics, child health clinics, and
expanded programme on immunisation
(EPI) services (‘‘keep up’’) [6]. The choice
of the combination is generally based on
existing coverage and status of available
distribution mechanisms in a given coun-
try. It is well recognised that, individually,
each mechanism is suboptimal to maintain
universal coverage and will leave some
gaps.
Use of ITNs among pregnant women is
well below national and international
targets; a recent meta-analysis of national
survey data in 37 countries for the years
2009–2011 estimated the median use of an
ITN the previous night among pregnant
women was 35.3% (range 5.2%–75.5%)
[7]. ITN use was higher in areas with both
a high disbursement of funds for malaria
control and a lower per-head gross
domestic product. Younger or adolescent,
unmarried, and less educated women are
significantly less likely to use ITNs, which
may be related to lower affordability and
in-household access among these women
[8].
Policy Forum articles provide a platform for health
policy makers from around the world to discuss the
challenges and opportunities in improving health
care to their constituencies.
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Summary Points
N Long-lasting insecticide treated nets (LLINs) are a powerful public health tool
and, when used by pregnant women, contribute to improving maternal,
neonatal, and infant health, with lasting benefits to the developing child.
N Use of LLINs among pregnant women is well below national and international
targets; the median use of an insecticide treated net (ITN) the previous night
among pregnant women across 37 countries for 2009–2011 was 35.3% (range,
5.2%–75.5%); ITN use was higher in areas with both a high disbursement of
funds for malaria control and a lower per-head gross domestic product.
N Routine antenatal care (ANC) services constitute an important delivery channel
that ensures pregnant women who attend an ANC clinic at least once (77% in
sub-Saharan Africa) are covered with a LLIN from their first ANC visit in each
pregnancy and plays an important role in maintaining population-level
coverage between campaigns, particularly for women who become pregnant
between campaigns and for infants born outside of campaign years.
N The majority of LLINs delivered from 2010–2012 in sub-Saharan Africa were
through mass campaigns as countries sought to reach the 80% coverage target,
and some of the LLINs used in these campaigns were re-allocated from routine
ANC delivery.
N Going forward, national malaria programmes and donors alike will have to
make difficult decisions to balance costs with the benefits and impact of
investments in LLINs. Where choices must be made, high-risk groups (pregnant
women and children under 5 years of age) should be prioritized for the same
reason these groups were targeted under the pre-universal coverage WHO
strategy.
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Public Health Rationale for Net
Distribution to Pregnant
Women
LLINs are a powerful public health tool
and, when used by pregnant women,
contribute to improving maternal, neona-
tal, and infant health, with long-lasting
benefits to the developing child. World-
wide, an estimated 125 million pregnan-
cies are at risk from malaria each year [9].
Pregnant women are 1.5 times more
susceptible to malaria infection than non-
pregnant women [10] and malaria infec-
tion can have devastating consequences on
maternal, newborn, infant, and child
health. In Africa, 10,000 women [11,12]
and between 75,000 and 200,000 infants
[13,14] are estimated to die annually as a
result of malaria infection during preg-
nancy, and approximately 11% (100,000)
of neonatal deaths are due to low birth
weight (LBW) resulting from Plasmodium
falciparum infections in pregnancy [15].
In the absence of malaria control in
pregnancy, it is estimated that 11.4 million
(95% credible interval [CrI], 10.7–12.1)
pregnancies would have experienced P.
falciparum placental infection at some
stage of pregnancy, accounting for 41%
of the estimated 27.6 million live births in
sub-Saharan Africa in 2010 [16]. Com-
bined with estimates of the relationship
between placental infection and the risk of
LBW, 900,000 (95% CrI, 530,000–
1,240,000) LBW deliveries per year were
estimated to be caused by placental
malaria. The end of the first trimester is
a key period during which 65% (95% CrI,
61%–70%) of the potentially infected
pregnancies first experience infection,
and primigravidae experience a high
proportion 39% (95% CrI, 33%–46%) of
the total potential malaria-attributable
LBW burden.
LLINs have been proven in clinical
trials and in field programs to substantially
reduce the adverse consequences of ma-
laria in pregnancy, reducing maternal
anaemia, severe anaemia, peripheral and
placental malaria, and low birth weight
[17–19], and LLINs are highly cost
effective [20]. As a consequence, LLINs,
along with intermittent preventive treat-
ment in pregnancy (IPTp) [17,21,22],
together with effective case management
of malaria, are recommended by WHO in
malaria endemic settings in Africa. At
2012 coverage levels across 32 countries in
sub-Saharan Africa, LLIN or IPTp use
among women in their first or second
pregnancies was significantly associated
with a decreased risk of neonatal mortality
(incidence rate ratio 0?82; 95% confidence
interval (CI), 0?698–0?96) and reduced
odds of low birth weight (adjusted odds
ratio 0?79; 95% CI 0?73–0?86), compared
with newborn babies of mothers with no
protection, after controlling for potential
confounding factors [23].
Routine Distribution through
Antenatal Care Clinics—An
Important ‘‘Keep Up’’ Strategy
The delivery of free or subsidized
LLINs (or vouchers) to pregnant women
through ANC services is a key strategy for
controlling malaria and increases coverage
and use by both pregnant women [24–27]
and their infants [24,25]. As infants in
most malaria-endemic settings sleep with
their mother during the first year of life (or
longer), the protective effect of an LLIN
delivered to a pregnant woman is there-
fore extended through the infant’s first
year of life.
Routine ANC services constitute an
important delivery channel that ensures
pregnant women who attend ANC at least
once (77% in sub-Saharan Africa) [28] are
covered with an LLIN from their first
ANC visit and in subsequent pregnancies
and plays an important role in maintain-
ing population-level coverage between
campaigns, particularly for women who
become pregnant between campaigns and
for infants born outside of campaign years
[29,30]. Whilst mass campaigns can rap-
idly scale up coverage, by as much as
30%–80% [31], universal coverage will
not be maintained without the continuous
distribution of LLINs, and ANC routine
services have proven effective for reaching
pregnant women [28,32–35].
In addition, campaign delivery of
LLINs to households with pregnant wom-
en [36], households with children under 5
years of age [37], or households with low
socioeconomic status [38] has shown
limited impact on increasing coverage
among pregnant women [8], supporting
the need for routine ANC services.
Notwithstanding important limitations of
modelling studies, which in the absence of
evidence use some assumptions (costs,
efficiencies of scale, data from a limited
number of countries, etc.), modelling has
demonstrated that a combination of an
ANC- and school-based distribution
would sustain the high coverage achieved
in recent years by the mass campaigns
[39]. Modelling also predicts that supple-
menting mass distribution campaigns with
ANC delivery could achieve a 1.4 times
greater reduction in child mortality than
mass distribution alone, as children born
between campaign years would be covered
during the most vulnerable time [40].
Delivery of LLINs through ANC to
pregnant women is an effective, sustain-
able strategy for continuous distribution
[41]; greater effort is needed to encourage
women to initiate ANC attendance early
in the first trimester, and promoting the
availability of a free ITN at early ANC
booking may encourage women to initiate
ANC earlier [41].
In short, the distribution of LLINs
through routine services, ANC services
included, is an important strategy and will
require a sustained commitment to health
systems strengthening; and neglecting this
strategy will impede a country’s ability to
maintain universal coverage over the
longer term. Delivery of LLINs through
ANC has been observed to increase
pregnant women’s attendance at ANC
clinics [42], which is an important plat-
form through which women receive other
essential antenatal care services, such as
prevention of mother to child transmission
of HIV (PMTCT); management of anae-
mia, syphilis, and other conditions; birth
planning; etc. In addition, ANC clinics
provide an opportunity to educate, inform,
and encourage women to use ITNs.
Recent Policy and Funding for
LLINs among Key Donors and
Partners
The policy shift towards universal
coverage reflects huge progress in malaria
control and is a laudable goal that has
injected enthusiasm into the global malar-
ia community and has attracted calls for
elimination. Notwithstanding, funding for
malaria control peaked at $US2 billion in
2011 [43] and has begun to decline,
ushering in an era of limited resources.
Amidst the push to achieve universal
coverage and dwindling resources, there
is the potential danger whereby ‘‘keep-up’’
strategies lose resources and funding to its
more attractive ‘‘catch-up’’ counterpart.
Despite recent encouraging statistics on
funding for continuous delivery systems,
including ANC, increasing from 22% in
2008–2010 of all funding commitments to
42% for the 2012–2016 funding interval
[44], the funding gap has meant that the
routine systems are the first to be left
unfunded. One estimate for 2013–2016
suggests current funding commitments
meet just over half of countries’ needs,
leaving a funding gap of approximately
374 million LLINs [43], and in a funding
review of the Global Fund to fight AIDS,
Tuberculosis, and Malaria and other
major donors the authors report that
70% of as-yet-unfunded LLINs are for
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continuous delivery systems [44]. The
majority of LLINs delivered from 2010–
2012 in sub-Saharan Africa were through
mass campaigns as countries sought to
reach the 80% coverage target [6,43].
Some of the LLINs used in these cam-
paigns were re-allocated by national
planners from routine ANC delivery to
fill gaps in campaigns, as reported in
Angola (2013), Cote d’Ivoire (2008), Ca-
meroon (2011), Democratic Republic of
Congo (2012, 2013), Kenya (2011), Ma-
lawi (2011), Nigeria (2014), Togo (2011),
and Uganda (2012, 2014) (Matthew
Lynch, Johns Hopkins University, person-
al communication, June 2014).
These trends prompted a policy recom-
mendation from the WHO Vector Control
Technical Expert Group to the Malaria
Policy Advisory Committee (MPAC) noting
that, although universal coverage was still
the priority, LLINs distributed through
routine channels such as ANC and EPI
should continue regardless of mass cam-
paign timing, and that nets for routine
distribution should not be diverted to
campaigns. This recommendation has been
approved by MPAC [45] and a policy
recommendation published [5].
Recommendations
The shortfall in funding for malaria,
generally, and for LLINs, in particular,
calls for endemic country programs, ma-
laria donors, implementing agencies, and
partners to adopt the most cost-effective
strategies to deliver this life-saving inter-
vention. The challenge will be to ensure
that population-wide coverage does not
fall while maintaining highest priority for
pregnant women and children. The argu-
ments for maintaining the ANC distribu-
tion mechanism are strong. This mecha-
nism reaches the highest risk population of
mothers and their newborns, takes advan-
tage of the fact that most pregnant women
visit ANC clinics, is the only antenatal
malaria prevention intervention that pro-
vides protection in the first trimester of
pregnancy, and adds an important benefit
to the focused ANC delivery system as it
serves to encourage ANC attendance.
Going forward, national malaria pro-
grammes and donors alike will have to
make difficult decisions to balance costs
with the benefits and impact of invest-
ments in LLINs. WHO’s MPAC has
recommended that routine LLIN distribu-
tion (through ANC and the EPI) continue
‘‘before, during, and after’’ campaigns,
and that recommendation needs to be
adopted by Ministries of Health and
donors [5,45]. For routine distribution to
continue, unaffected by campaigns, donors
need to make their funding commitments
for LLIN procurement for both routine
and campaign delivery explicit and well in
advance (2 years minimum), to allow
governments to plan ahead for both
catch-up and keep-up. Governments will
need to track both stock of LLINs and
their coverage and ensure that there are
sufficient commodities for delivery
through both routine and campaign
strategies, requiring quality data on
ANC delivery of LLINs, both through
strengthened Health Management Infor-
mation System reporting of LLIN distri-
bution and through national surveys.
Where choices must be made, high-risk
groups (pregnant women and children
under 5 years of age) should be priori-
tized for the same reason these groups
were targeted under the pre-universal
coverage WHO strategy. Receiving a net
as an integral part of antenatal care
sends a powerful message to a pregnant
woman that this tool is important to
protect herself and her child. Ministries
of Health need to maximise ANC
opportunities, for example, to use LLINs
delivery at ANC clinics to promote
earlier and increased demand for ANC,
and vice versa.
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